Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics crawled date : 2022 - 09 - 07 save search
Pear Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Published: 2022-09-07 (Crawled : 23:00) - biospace.com/
MS | News 0 d | $92.09 1.58% 0.12% 2.9K
|
Finance
|
| O: -0.89%
H: 3.43%
C: 2.95%
global conference therapeutics
Mirati Therapeutics Presents Late-Breaking Adagrasib Monotherapy and Combination Results in Advanced Colorectal Cancer
Published: 2022-09-07 (Crawled : 23:00) - prnewswire.com
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.57%
H: 8.57%
C: 5.65%
therapeutics results cancer
CytomX Therapeutics Presents Overview of Conditionally-Activated Antibody-Drug Conjugate (ADC) Programs Including Next Generation EpCAM-Targeting CX-2051
Published: 2022-09-07 (Crawled : 23:00) - globenewswire.com
CTMX | $1.67 0.3% 300
|
Health Technology
|
| O: -1.82%
H: 4.63%
C: 3.7%
cx-2051 therapeutics
Oncternal Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-07 (Crawled : 22:00) - biospace.com/
ONCT | $8.55 -3.5% 4.12% 1.7K
|
Health Technology
|
| O: 0.0%
H: 3.81%
C: 1.9%
global conference therapeutics
Seres Therapeutics Announces Completion of Rolling BLA Submission to FDA for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection
Published: 2022-09-07 (Crawled : 14:20) - biospace.com/
MCRB | $0.6246 11.56% 9.71% 46K
|
Health Technology
|
| O: 1.67%
H: 15.94%
C: 15.12%
ser-109 fda therapeutics infection submission
Bicycle Therapeutics Announces BT5528 Phase I Dose Escalation Results in Patients with Advanced Solid Tumors
Published: 2022-09-07 (Crawled : 14:20) - biospace.com/
BCYC | $22.57 -3.75% -4.04% 400K
|
Health Technology
|
| O: -1.03%
H: 5.83%
C: 1.16%
bt5528 therapeutics bicycle results
Edgewise Therapeutics Announces FDA Authorization for Phase 2 Clinical Trial of EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (DMD)
Published: 2022-09-07 (Crawled : 14:20) - biospace.com/
EWTX | $15.08 -0.99% -1.2% 380K
|
Manufacturing
|
| O: 0.0%
H: 9.63%
C: 8.29%
edg-5506 treatment fda trial therapeutics duchenne authorization phase 2
SpringWorks Therapeutics Announces $225 Million Private Placement Financing
Published: 2022-09-07 (Crawled : 14:00) - globenewswire.com
SWTX | $42.89 6.96% 6.46% 870K
|
Health Technology
|
| O: -0.38%
H: 15.79%
C: 7.56%
therapeutics
Viracta Therapeutics Announces Orphan Drug Designation Granted by the European Commission for Nana-val for the Treatment of Peripheral T-cell Lymphoma
Published: 2022-09-07 (Crawled : 13:20) - biospace.com/
VIRX | $0.88 2.72% -3.3% 14K
|
Manufacturing
|
| O: 1.16%
H: 12.64%
C: 10.57%
treatment designation drug t-cell granted therapeutics
Iterum Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-07 (Crawled : 13:20) - globenewswire.com
ITRM | $1.58 10.49% 10.06% 0
|
Health Technology
|
| O: 4.62%
H: 5.05%
C: 3.21%
global conference therapeutics
G1 Therapeutics to Participate Virtually in the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-07 (Crawled : 12:20) - globenewswire.com
GTHX | $4.1 -0.24% -0.24% 26K
|
Health Technology
|
| O: -0.44%
H: 12.02%
C: 11.36%
global conference therapeutics
Outlook Therapeutics® to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-07 (Crawled : 12:20) - globenewswire.com
OTLK | News P | $8.09 -0.98% -1.24% 410
|
Health Technology
|
| O: 0.92%
H: 3.64%
C: 2.73%
therapeutics global conference
Spero Therapeutics to Present at Upcoming Investor Conference
Published: 2022-09-07 (Crawled : 12:20) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 9.73%
H: 20.97%
C: 15.32%
conference therapeutics
Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines
Published: 2022-09-07 (Crawled : 12:00) - biospace.com/
BEAM | $24.1 0.84% 0.95% 0
|
Health Technology
|
| O: 0.25%
H: 6.45%
C: 5.18%
therapeutics
Voyager Therapeutics Appoints Peter Pfreundschuh as CFO; Todd Carter, Ph.D., as Chief Scientific Officer; and Trista Morrison as SVP Corporate Affairs
Published: 2022-09-07 (Crawled : 12:00) - ir.voyagertherapeutics.com
JNJ | News | $149.12 0.82% 0.59% 440K
|
Health Technology
|
| O: -0.65%
H: 0.93%
C: 0.71%
VYGR | News | $7.57 0.93% 0.92% 320K
|
Health Technology
|
| O: 0.78%
H: 6.81%
C: 6.81%
URGN | $14.37 4.66% 4.45% 280K
|
Health Technology
|
| O: -0.82%
H: 7.19%
C: 3.87%
IRWD | $8.06 1.77% 1.74% 1
|
Health Technology
|
| O: -0.19%
H: 2.86%
C: 1.91%
therapeutics
Value of Gout Therapeutics Market Estimated at US$ 4.9 Bn by 2031, TMR Study
Published: 2022-09-07 (Crawled : 12:00) - prnewswire.com
NVSEF | News | $95.11 5.4% 6.88% 0
|
Health Technology
|
| O: 4.71%
H: 0.0%
C: 0.0%
TAK | News | $13.36 0.91% 0.0% 1.5M
|
Health Technology
|
| O: -1.5%
H: 1.21%
C: 1.06%
NVS | News | $95.12 0.81% 4.36% 160K
|
Health Technology
|
| O: 0.66%
H: 0.88%
C: 0.8%
therapeutics study market
Trevi Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-07 (Crawled : 12:00) - prnewswire.com
TRVI | $2.94 3.7% 4.22% 200K
|
Health Technology
|
| O: 0.31%
H: 6.48%
C: 0.0%
global conference therapeutics
LAVA Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-07 (Crawled : 12:00) - globenewswire.com
LVTX | $2.85 5.17% 5.74% 2
|
|
| O: 8.55%
H: 0.0%
C: -7.48%
global conference therapeutics
Arch Therapeutics Launches Multi-Site Clinical Study for AC5® Advanced Wound System
Published: 2022-09-07 (Crawled : 11:00) - globenewswire.com
ARTH | $1.18 12.38% -17.78% 0
|
Manufacturing
|
| O: 5.26%
H: 25.0%
C: -2.5%
ac5 system therapeutics study
Relief Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-07 (Crawled : 09:00) - biospace.com/
RLFTF | $1.45 11.45% 1.3K
|
n/a
|
| O: -11.99%
H: 14.62%
C: 9.3%
global conference therapeutics
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
CANG | $1.34 -4.29% 14.93% 120K
|
Technology Services
AZTR 4 | $0.195 13.85% 42K
|
n/a
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
IBRX | $4.94 -6.26% 10.83% 4.5M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.